Cynthia Pussinen
Amministratore Delegato presso SERNOVA CORP.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Cynthia Pussinen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SERNOVA CORP. | Direttore/Membro del Consiglio | 05/09/2023 | - |
| Amministratore Delegato | 05/09/2023 | - |
Storia della carriera di Cynthia Pussinen
Precedenti posizioni note di Cynthia Pussinen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/02/2021 | 01/12/2022 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Formazione di Cynthia Pussinen
| Rensselaer Polytechnic Institute | Graduate Degree |
| University of Connecticut | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Canada | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SERNOVA CORP. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Cynthia Pussinen
- Esperienza
